TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07216443: Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Sponsor: Orca Biosystems, Inc. · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 80 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$3,095,400

Rescue Site Savings

+$2,032,800

Unlock Full NCT07216443 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07216443 Rescue Dossier →